[MDGL] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
28-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -13.63%
YoY- -28.09%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 770 0 0 0 0 0 0 -
PBT -112,194 -85,905 -64,549 -59,123 -27,740 -11,475 -8,445 53.86%
Tax 98 1,682 -106 -116 -28 -25 -276 -
NP -112,194 -87,587 -64,549 -59,123 -27,740 -11,475 -8,445 53.86%
Tax Rate - - - - - - - -
Total Cost 112,964 87,587 64,549 59,123 27,740 11,475 8,445 54.04%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -14,570.65 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -5.68 -5.08 -3.78 -3.82 -1.80 -0.75 -0.67 42.77%
EPS Diluted -5.68 -5.08 -3.78 -3.82 -1.80 -0.75 -0.67 42.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.